Details of the Drug Reposition

General Information of This Drug (ID: DMSJZB9)

Drug Name
CV-301   DMSJZB9

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
4 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Non-small-cell lung cancer DIS5Y6R9 2C25.Y Phase 2 [1]
Breast cancer DIS7DPX1 2C60-2C65 Phase 2 [2]
Bladder cancer DISUHNM0 2C94 Phase 2 [3]
Diabetic neuropathy DISX6VF8 8C0Z Phase 2 [2]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800019475)
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)